Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 0.00 (-0.14%)
As of: Oct 22, 2026 · 9:53 AM EDT

Telomir Pharmaceuticals (TELO) Long-Term Debt Repayments (2023 - 2024)

Updated

Telomir Pharmaceuticals (TELO) recorded Long-Term Debt Repayments of -$85,529 in Q3 2024.

Analysis

Telomir Pharmaceuticals (TELO) Long-Term Debt Repayments (2023 - 2024) Analysis & Trends

On a TTM basis, Telomir Pharmaceuticals' Long-Term Debt Repayments came in at $751,335 as of Sep 30, 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 1.00 Mn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn 2.00 Bn
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 2.46 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn -
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Telomir Pharmaceuticals 61.97 Mn 41.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -85,529.00
Mar 31, 2024 519,475.00
Jun 30, 2023 317,389.00
Mar 31, 2023 263,873.00
API Access

Telomir Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=TELO&period=max&api_key=YOUR_API_KEY